Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For EVOTF
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -4.08 1.86 1.94
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -148.02 -12.49 -5.04
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.40 6.24 6.33
Cash -15.76 2.88 3.41
Capex 40.81 -0.22 -0.37
Free Cash Flow -82.31 -0.49 -0.27
Revenue 3.47 1.18 1.14
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -11.00 0.17 0.19
Operating Margin -7.40 -0.13 -0.12
ROA -33.40 < 0.005 < 0.005
ROE -29.71 -0.02 -0.01
ROIC -82.11 -0.01 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of EVOTF is permitted for members.
5 Growth
The "Growth Entry" for the Focus of EVOTF is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of EVOTF is permitted for members.